Company news

Picard Medical, Inc. (AMEX:PMI) news

Picard Medical, Inc. news releases on 6ix. Latest, Aug 19, 2026: Picard Medical Reports Second Quarter 2026 Financial Results

View Picard Medical, Inc. →

Press releases & updates

Picard Medical Reports Second Quarter 2026 Financial Results

August 19, 2026

Picard Medical Receives NYSE American Acceptance of Compliance Plan

July 27, 2026

Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

July 20, 2026

Picard Medical Announces Leadership Transition

June 24, 2026

PICARD MEDICAL, INC. Issues Letter to Shareholders

May 29, 2026

Picard Medical, SynCardia Reports First Quarter 2026 Financial Results

May 22, 2026

Picard Medical / SynCardia Reports First Quarter 2026 Financial Results

May 21, 2026

Picard Medical : Amendment to Annual Report (Form 10-K/A)

May 15, 2026

Picard Medical Announces Pricing of $5 Million Offering

May 5, 2026

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

April 29, 2026

Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026

April 22, 2026

Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product

April 17, 2026

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

April 16, 2026

Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children's Hospital

April 15, 2026

Philip Morris International Joins Ferrari Hypersail as Principal Partner, Building on 50-Year Relationship

April 13, 2026

Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week

April 2, 2026

Picard Medical / SynCardia to Participate in Voice of the Patient Event During AZ Tech Week

April 1, 2026

Philip Morris International Presents its Value Report 2025: change in motion

March 31, 2026

Picard Medical Reports Full Year 2025 Financial Results

March 25, 2026

Perseverance Metals Issues Incentive Stock Options

March 24, 2026

Perseverance Metals Closes $4.7M Second and Final Tranche of Private Placement for Total Gross Proceeds of $8.2M

March 23, 2026

Picard Medical / SynCardia to Present its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology’s Annual Scientific Session

March 20, 2026

Picard Medical / SynCardia Highlight Second Successful Total Artificial Heart Bridge to Transplant at UCSF Health

March 19, 2026

Picard Medical / SynCardia Announce Successful Four-Year Bridge to Transplant with SynCardia Total Artificial Heart Support

March 17, 2026

Picard Medical / SynCardia Highlight Total Artificial Heart on BTV Program Airing on FOX Business News

March 13, 2026

Picard Medical / SynCardia to Host Annual Business Update Featuring Key Opinion Leaders and Patient Testimonial

March 12, 2026

Picard Medical / SynCardia Showcases Leadership in Total Artificial Heart Therapy at Technology and Heart Failure Therapeutics Conference

March 2, 2026

Picard Medical / SynCardia to Participate in Inaugural “Hands-On Training Day” at the Technology and Heart Failure Therapeutics Conference

February 26, 2026

Leading Heart Transplant Centers Convene in Houston for Picard Medical/ SynCardia’s Total Artificial Heart Surgical Training

February 23, 2026

Picard Medical/ SynCardia Highlights Successful Bridge-to-Transplant Case at UCSF Health Using the SynCardia Total Artificial Heart

February 12, 2026

Picard Medical/ SynCardia to Present at European Mechanical Circulatory Support Summit and International Course on Mechanical Circulatory Support and New Technologies in Heart Failure

February 10, 2026

Picard Medical / SynCardia to Present Webinar on the Emperor Fully Implantable Total Artificial Heart Hosted by DeviceTalks

January 29, 2026

Picard / SynCardia Featured on the Cruxx of MedTech Podcast

January 13, 2026

SynCardia and Hydrix Enter into Development Collaboration to Advance the Emperor, SynCardia’s Next Generation Total Artificial Heart

January 12, 2026

Picard Medical Announces Conference Participation During J.P. Morgan Healthcare Conference Week

January 7, 2026

Picard Medical to Begin Rollout of FDA-Cleared Accessory for its SynCardia Total Artificial Heart

January 6, 2026

Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors

December 30, 2025

Picard Medical Announces Up to $50 Million Senior Secured Debt Financing

December 24, 2025

Picard Medical Marks Public Company Milestone by Ringing the NYSE Opening Bell

December 18, 2025

Picard Celebrates Patient Living a World-Record of Over Eight Years with the SynCardia Total Artificial Heart

December 9, 2025

Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany

December 3, 2025

Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025

November 26, 2025

SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart

November 19, 2025

Picard Reports Third Quarter 2025 Financial Results

November 14, 2025

Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City

November 12, 2025

Picard to Showcase its Total Artificial Heart at the Annual Meeting of the American Heart Association 2025

November 3, 2025

Picard Issues Statement on Intraday Stock Price

October 24, 2025

Perseverance Metals to Commence Trading on TSXV Under Symbol 'PMI' Following $8.2 Million Go-Public Financing

October 13, 2025

Perseverance Announces Conversion of Subscription Receipts and Satisfaction of the Lac Gayot Free Carry Right

October 10, 2025

Perseverance to Commence Trading on the TSXV & Satisfies Escrow Release Conditions

October 8, 2025

Older →